Goldman Sachs’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218M | Sell |
|
|||||
|
2025
Q1 | $175M | Sell |
|
|||||
|
2024
Q4 | $204M | Buy |
|
|||||
|
2024
Q3 | $152M | Sell |
|
|||||
|
2024
Q2 | $414M | Buy |
|
|||||
|
2024
Q1 | $331M | Sell |
|
|||||
|
2023
Q4 | $307M | Buy |
|
|||||
|
2023
Q3 | $205M | Sell |
|
|||||
|
2023
Q2 | $339M | Sell |
|
|||||
|
2023
Q1 | $321M | Buy |
|
|||||
|
2022
Q4 | $298M | Buy |
|
|||||
|
2022
Q3 | $211M | Buy |
|
|||||
|
2022
Q2 | $180M | Sell |
|
|||||
|
2022
Q1 | $422M | Buy |
|
|||||
|
2021
Q4 | $341M | Buy |
|
|||||
|
2021
Q3 | $301M | Buy |
|
|||||
|
2021
Q2 | $182M | Buy |
|
|||||
|
2021
Q1 | $143M | Buy |
|
|||||
|
2020
Q4 | $126M | Sell |
|
|||||
|
2020
Q3 | $451M | Sell |
|
|||||
|
2020
Q2 | $495M | Buy |
|
|||||
|
2020
Q1 | $173M | Buy |
|
|||||
|
2019
Q4 | $116M | Buy |
|
|||||
|
2019
Q3 | $73.4M | Buy |
|
|||||
|
2019
Q2 | $68.2M | Sell |
|
|||||
|
2019
Q1 | $59.1M | Buy |
|
|||||
|
2018
Q4 | $44.2M | Sell |
|
|||||
|
2018
Q3 | $101M | Sell |
|
|||||
|
2018
Q2 | $76.7M | Sell |
|
|||||
|
2018
Q1 | $126M | Buy |
|
|||||
|
2017
Q4 | $89.2M | Sell |
|
|||||
|
2017
Q3 | $89.9M | Buy |
|
|||||
|
2017
Q2 | $132M | Buy |
|
|||||
|
2017
Q1 | $119M | Sell |
|
|||||
|
2016
Q4 | $89.2M | Buy |
|
|||||
|
2016
Q3 | $81.1M | Buy |
|
|||||
|
2016
Q2 | $72.6M | Sell |
|
|||||
|
2016
Q1 | $94.8M | Sell |
|
|||||
|
2015
Q4 | $120M | Sell |
|
|||||
|
2015
Q3 | $136M | Sell |
|
|||||
|
2015
Q2 | $128M | Buy |
|
|||||
|
2015
Q1 | $50.4M | Buy |
|
|||||
|
2014
Q4 | $30.9M | Sell |
|
|||||
|
2014
Q3 | $23.2M | Sell |
|
|||||
|
2014
Q2 | $26M | Sell |
|
|||||
|
2014
Q1 | $32.1M | Buy |
|
|||||
|
2013
Q4 | $21.7M | Sell |
|
|||||
|
2013
Q3 | $20.5M | Buy |
|
|||||
|
2013
Q2 | $13.4M | Buy |
|